PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV

The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a therapeutic oligonucleotide targeting HBV and a TLR7 agonist for use in the treatment of a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHU, YONGHONG, JIN, YUYAN, GAO, LU, OTTOSEN, SOREN, MUELLER, HENRIK, TYAGI, GAURAV, BLAISING, JULIE ELISABETH FRANCOISE, BO, QINGYAN, ZHOU, XUE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	ZHU, YONGHONG JIN, YUYAN GAO, LU OTTOSEN, SOREN MUELLER, HENRIK TYAGI, GAURAV BLAISING, JULIE ELISABETH FRANCOISE BO, QINGYAN ZHOU, XUE
description	The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a therapeutic oligonucleotide targeting HBV and a TLR7 agonist for use in the treatment of a chronic hepatitis B patient. La présente invention concerne des compositions et des méthodes de traitement d'une infection par le virus de l'hépatite B. Plus précisément, la présente invention concerne une polythérapie comprenant l'administration d'un oligonucléotide thérapeutique ciblant le VHB et un agoniste de TLR7 destinée à être utilisée pour le traitement d'un patient atteint d'hépatite B chronique.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3163490A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3163490A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3163490A13</originalsourceid><addsrcrecordid>eNqNzMEKgkAQxnEvHaJ6h3mBIDGKjuM6ugPrjmxjV5HYTlGGvT9p9ACdvsP_x7dMXo3FUKOhVtmgAyN1zh6VxYOUgKCWAjbfDOK4Et8aR6JcECiGipR9BTa_APpi9i4cASfGZ4VSAmgg1Jq8zn-TWyeLW38f4-a3qwRKUmO3cXh2cRz6a3zEd2cwSw_Z_rTDNPuDfACHnjdJ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV</title><source>esp@cenet</source><creator>ZHU, YONGHONG ; JIN, YUYAN ; GAO, LU ; OTTOSEN, SOREN ; MUELLER, HENRIK ; TYAGI, GAURAV ; BLAISING, JULIE ELISABETH FRANCOISE ; BO, QINGYAN ; ZHOU, XUE</creator><creatorcontrib>ZHU, YONGHONG ; JIN, YUYAN ; GAO, LU ; OTTOSEN, SOREN ; MUELLER, HENRIK ; TYAGI, GAURAV ; BLAISING, JULIE ELISABETH FRANCOISE ; BO, QINGYAN ; ZHOU, XUE</creatorcontrib><description>The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a therapeutic oligonucleotide targeting HBV and a TLR7 agonist for use in the treatment of a chronic hepatitis B patient. La présente invention concerne des compositions et des méthodes de traitement d'une infection par le virus de l'hépatite B. Plus précisément, la présente invention concerne une polythérapie comprenant l'administration d'un oligonucléotide thérapeutique ciblant le VHB et un agoniste de TLR7 destinée à être utilisée pour le traitement d'un patient atteint d'hépatite B chronique.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210701&DB=EPODOC&CC=CA&NR=3163490A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210701&DB=EPODOC&CC=CA&NR=3163490A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHU, YONGHONG</creatorcontrib><creatorcontrib>JIN, YUYAN</creatorcontrib><creatorcontrib>GAO, LU</creatorcontrib><creatorcontrib>OTTOSEN, SOREN</creatorcontrib><creatorcontrib>MUELLER, HENRIK</creatorcontrib><creatorcontrib>TYAGI, GAURAV</creatorcontrib><creatorcontrib>BLAISING, JULIE ELISABETH FRANCOISE</creatorcontrib><creatorcontrib>BO, QINGYAN</creatorcontrib><creatorcontrib>ZHOU, XUE</creatorcontrib><title>PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV</title><description>The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a therapeutic oligonucleotide targeting HBV and a TLR7 agonist for use in the treatment of a chronic hepatitis B patient. La présente invention concerne des compositions et des méthodes de traitement d'une infection par le virus de l'hépatite B. Plus précisément, la présente invention concerne une polythérapie comprenant l'administration d'un oligonucléotide thérapeutique ciblant le VHB et un agoniste de TLR7 destinée à être utilisée pour le traitement d'un patient atteint d'hépatite B chronique.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzMEKgkAQxnEvHaJ6h3mBIDGKjuM6ugPrjmxjV5HYTlGGvT9p9ACdvsP_x7dMXo3FUKOhVtmgAyN1zh6VxYOUgKCWAjbfDOK4Et8aR6JcECiGipR9BTa_APpi9i4cASfGZ4VSAmgg1Jq8zn-TWyeLW38f4-a3qwRKUmO3cXh2cRz6a3zEd2cwSw_Z_rTDNPuDfACHnjdJ</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>ZHU, YONGHONG</creator><creator>JIN, YUYAN</creator><creator>GAO, LU</creator><creator>OTTOSEN, SOREN</creator><creator>MUELLER, HENRIK</creator><creator>TYAGI, GAURAV</creator><creator>BLAISING, JULIE ELISABETH FRANCOISE</creator><creator>BO, QINGYAN</creator><creator>ZHOU, XUE</creator><scope>EVB</scope></search><sort><creationdate>20210701</creationdate><title>PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV</title><author>ZHU, YONGHONG ; JIN, YUYAN ; GAO, LU ; OTTOSEN, SOREN ; MUELLER, HENRIK ; TYAGI, GAURAV ; BLAISING, JULIE ELISABETH FRANCOISE ; BO, QINGYAN ; ZHOU, XUE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3163490A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHU, YONGHONG</creatorcontrib><creatorcontrib>JIN, YUYAN</creatorcontrib><creatorcontrib>GAO, LU</creatorcontrib><creatorcontrib>OTTOSEN, SOREN</creatorcontrib><creatorcontrib>MUELLER, HENRIK</creatorcontrib><creatorcontrib>TYAGI, GAURAV</creatorcontrib><creatorcontrib>BLAISING, JULIE ELISABETH FRANCOISE</creatorcontrib><creatorcontrib>BO, QINGYAN</creatorcontrib><creatorcontrib>ZHOU, XUE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHU, YONGHONG</au><au>JIN, YUYAN</au><au>GAO, LU</au><au>OTTOSEN, SOREN</au><au>MUELLER, HENRIK</au><au>TYAGI, GAURAV</au><au>BLAISING, JULIE ELISABETH FRANCOISE</au><au>BO, QINGYAN</au><au>ZHOU, XUE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV</title><date>2021-07-01</date><risdate>2021</risdate><abstract>The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a therapeutic oligonucleotide targeting HBV and a TLR7 agonist for use in the treatment of a chronic hepatitis B patient. La présente invention concerne des compositions et des méthodes de traitement d'une infection par le virus de l'hépatite B. Plus précisément, la présente invention concerne une polythérapie comprenant l'administration d'un oligonucléotide thérapeutique ciblant le VHB et un agoniste de TLR7 destinée à être utilisée pour le traitement d'un patient atteint d'hépatite B chronique.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_CA3163490A1
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
title	PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T19%3A23%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHU,%20YONGHONG&rft.date=2021-07-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3163490A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true